Pharmacokinetic Study of Paracetamol.

• Status: Unknown status
• Trial end date: 2020-02-03
• Target enrollment: 0
• Participant gender: Male

Summary

Brief Summary:

The study evaluate the absorption rate and pharmacodynamic of different formulation of paracetamol either in the form of normal tablets or a new rapid absorbable gelation capsule formulation "Paracetamol1523" by determining T-max and area under the response curve of paracetamol in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kolding Sygehus
• Treatments: Acetaminophen

Criteria

Inclusion Criteria:

• Normal healthy volunteers

• Must be able to swallow tablets

Exclusion Criteria:

• Diabetes

• Thyroid disease

• any medial treatment